CMO demand jumped during the COVID-19 pandemic

Amy Baxter | | Health Exec | Leadership
doctor.jpg

Chief medical officer is the hottest job title in the healthcare field over the past few years, according to recent data that revealed a jump in demand during the COVID-19 pandemic. 

More than 2,900 jobs for CMOs were posted in 2022, according to Yahoo, citing data from Zip Recruiter. That’s compared to just 767 postings for the job title in 2019, and a record of 5,000 postings last year.

Interestingly, the need for CMOs spread across industries, with the healthcare industry seeing an obvious uptick in demand, but other industries as well. Non-healthcare companies typically required a clinician for operational and employee health management needs, Yahoo reported. 

Healthcare is a huge cost for companies, and managing employees’ health has created a new dynamic across industries that will stretch beyond the COVID-19 pandemic. Helping employees navigate the healthcare space can be beneficial for both employees and companies. 

See the full story below:

Demand for chief medical officer roles skyrocketed during pandemic

Related Content

Q&A: Bicycle Health CMO breaks down telehealth’s role in the opioid crisis
CVS appoints new CMO
Humana CMO on the role of AI in an integrated care landscape
Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Why more doctors should pursue business and leadership training
Is the job market for health execs about to undergo a shakeout?
Congenital heart surgeon named president of the American Association for Thoracic Surgery
Cardiologist became paralyzed after wearing heavy aprons in the cath lab for decades—but he fought back
The top 25 heart hospitals in the United States
Veteran surgeon unpacks major changes in the world of cardiac surgery

Around the web

Cardiovascular Business
AMA agrees to help after initial request for an independent cardiovascular board was denied

After their proposal for a new American Board of Cardiovascular Medicine was shot down earlier this year, cardiology groups have asked the AMA for some support. "We feel like it's time for us to blaze our own path," one specialist explained. 

Cardiovascular Business
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Cardiovascular Business
AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.